Geron Corp. (NASDAQ: GERN) is getting a reality check on Wednesday. After a recovery from years of disappointment, this is starting to feel again like the Geron that everyone knew before. Wednesday’s drop is by more than half after the company issued a press release saying that it has received verbal notice from the U.S. Food and Drug Administration (FDA) has placed a full clinical hold on Geron’s Investigational New Drug application for imetelstat. Geron Corporation (NASDAQ:GERN) stock opened at $1.66 in last session, and closed at $1.69, while the day range of GERN stock is $1.39-$1.82.The stock showed a negative weekly performance of -64.57%.
Energy Corporation (NYSEMKT:ZBB) The Energy Corporation (NYSEMKT:ZBB)’s on Mar. 11 announced that in view of the unusual market activity in the Company’s stock, NYSE MKT has contacted the company in accordance with its normal practice and requested the Company respond by press release. The Company stated that its policy is not to comment on unusual market activity. Energy XXI (Bermuda) Limited (NASDAQ:EXXI) stock opened at $21.49, in last session and closed at $21.54, by loosed -7.83%. The 52 week range was $20.40-$33.93. Company’s market capitalization is $12.71 billion.
The Zogenix, Inc.(NASDAQ:ZGNX) on Mar. 5 reported financial results for the fourth quarter and full year ended December 31, 2013. Total revenues for the fourth quarter 2013, which consist of net product revenue and service and other revenue, were $9.9 million, up from $9.5 million in the fourth quarter 2012. Zogenix, Inc. (NASDAQ:ZGNX) stock loosed -22.69% and finished the last session at $3.51. The EPS of the stock remained -0.44. Company’s market capitalization is $289.78 million.
Equities researchers at JMP Securities dropped their price target on shares of Synta Pharmaceuticals Corp. (NASDAQ:SNTA) from $14.00 to $10.00 in a research report issued on Wednesday, Stock Ratings Network reports. JMP Securities’ price target would indicate a potential upside of 119.78% from the company’s current price. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) stock opened the session at $4.62, and closed the session at $4.55. The 52 week range of the SNTA stock remained $3.70-$10.74 and the day range was $4.34-$4.70.